AFP12m
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
How DeepSeek and next-generation AI agents could erode value of language models
Executives at leading AI labs say that large language models like those from OpenAI and Big Tech firms risk becoming ...